| 期刊論文1. | Irwin, Alan(2001)。Constructing the scientific citizen: Science and democracy in the biosciences。Public Understanding of Science,10(1),1-18。 | 2. | Frankenfeld, Philip J.(1992)。Technological Citizenship: A Normative Framework for Risk Studies。Science, Technology and Human Values,17(4),459-484。 | 3. | McEntire, D. A.(2001)。Triggering agents, vulnerabilities and disaster reduction: Towards a holistic paradigm。Disaster Prevention and Management: An International Journal,10(3),189-196。 | 4. | (2003)。首次生技產業發展意見問卷出爐,台灣生技CEO對產業發展大調查。生技時代,15。 延伸查詢 | 5. | 陳昭義(1997)。科技專案理念與運作。技術尖兵,29,1-2。 延伸查詢 | 6. | 魏汎娟(20010700)。胚胎幹細胞(embryonic stem cells)研究所引發爭議之討論。生物科技與法律研究通訊,11,6-15。 延伸查詢 | 7. | Abraham, J.、Lewis, G.(1999)。Harmonising and competing for medicines regulation: how health are the European Union's system of drug approval。Social Science and Medicine,18,655-667。 | 8. | Banta, H. D.(1996)。Coordination of health technology assessment in Europe。Eurohealth,2(4),11-13。 | 9. | Battista, R. N.、Banta, H. D.、Jonsson, E.、Hodge, M.、Gelband, H.(1994)。Lessons from the Eight Countries。Health Policy,30,397-421。 | 10. | Beck-Gemsheim, Elisabeth(1996)。Die soziale Konstruktion des Risikos -- das Beispiel Pränataldiagnostik。Soziale Welt,47,284-296。 | 11. | Bowonder, B.、Miyake, T.、Muralidharan, B.(1999)。Predicting the future: lessons from evolutionary theory。Technological Forecasting & Social Change,62,1-2。 | 12. | Brunner, R. D.(1999)。Predictions and Policy Decisions。Technological Forecasting and Social Change,62,73-78。 | 13. | 朱世霓(2001)。英政府下達禁令禁止保險業者使用基因檢測結果。科技法律透析,13(12)。 延伸查詢 | 14. | 黃達夫(19941000)。醫療照護之新經濟觀--我國醫療科技評估之需要性及優先性設定。醫望雜誌,4,53-55。 延伸查詢 | 15. | 黃麗華(2000)。二十一世紀的醫療新科技--基因治療。生物醫學報導,1,11-13。 延伸查詢 | 16. | 楊長興、陳雪芬、陳楚杰(20001200)。醫療科技評估簡介。醫院,33(6),1-8。 延伸查詢 | 17. | 羅恆廉(2003)。臨床診療指引(Clinical Practice Guideline, CPG)。財團法人醫院評錄暨醫療品質策進會簡訊,4(3),1-11。 延伸查詢 | 18. | 魯貴顯(20001000)。基因技術的風險與管制--社會學系統理論的觀點。生物科技與法律研究通訊,8,38-53。 延伸查詢 | 19. | 程樹德(20020600)。人類基因體解碼後的商機。科學發展月刊,354,12-17。 延伸查詢 | 20. | 賴沅暉(20030600)。生物醫學科技發展下的治理機制變遷:以胚胎幹細胞研究之發展為例。行政暨政策學報,36,155-187。 延伸查詢 | 21. | 賴沅暉(20040900)。新興科技發展對政策過程的影響:以健康照護政策中之醫療科技評估為例。公共行政學報. 政大,12,93-129。 延伸查詢 | 22. | Abraham, J.、Lewis, G.(1998)。Secrecy and Transparency of Medicines Licensing in the EU。The Lancet,352,480-482。 | 23. | Assheuer, Thomas(2000)。Die neue Genmystik。Die Zeit,28。 | 24. | Baird, P. A.(2000)。Genetic technologies and achieving health for populations。International Journal of Health Service,30(2),407-424。 | 25. | Baird, P. A.(2001)。The Human Genome Project, Genetics, and Health。Community Genetics,4(2),77-80。 | 26. | Bams, I.、Schibeci, R.、Davison, A.、Shaw, R.(2000)。What do you think about genetic medicine: facilitating sociable public discourse on developments in the new genetics。Science, Technology & Human Values,25(3),283-308。 | 27. | Banta, H. D.(2001)。The Management of Health Technology From a National Perspective。International Journal of Health Technology & Management,3(2/3/4),177-190。 | 28. | Banta, H. D.、Oortwij, W.(2000)。Health technology assessment and the European Union。International Journal of Technology Assessment in Health Care,16,299-302。 | 29. | Bapat, B.、Noorani, H.、Cohen, Z.(1999)。Cost comparison of predictive genetic testing versus conventional clinical screening for familial adenomatous polyposis。Gut,44(5),698-703。 | 30. | Becker, M. H.(1985)。Patient Adherence to Prescribed Therapies。Medical Care,23(5),539-555。 | 31. | Ong, B. N.(1996)。The Lay Perspective in Health Technology Assessment。International Journal of Technology Assessment in Health Care,12(3),511-517。 | 32. | Chacko, G. K.(1999)。Chief Technology Officers (CTOs) in Historic Survival Decisions of Countries and Corporations。Technological Forecasting and Social Change,62(1/2),41-50。 | 33. | Coates, J. F.(2001)。A 21st century agenda for technology assessment。Technological Forecasting and Social Change,67(2/3),303-308。 | 34. | Cook-Deegan, R. M.、McCormack, S. J.(2001)。Patents, Secrecy, and DNA。Science,293(5528),217-219。 | 35. | Craig, I. W.、McClay, J.、Plomin, R.、Freeman, B.(2000)。Chasing behaviour genes into the next millennium。Trends in Biotechnology,18(1),22-26。 | 36. | Dickson, D.(2001)。UK clinical geneticists ask for ban on the patenting of human genes。Nature,366,391。 | 37. | Franklin, S.(1999)。What we know and what we don't about cloning and society。New Genetics and Society,18(1),111-120。 | 38. | Frewer, L. J.、Howard, C.、Hedderley, D.、Shepherd, R.(1999)。Reactions to information about genetic engineering: impact of source credibility, perceived risk immediacy and persuasive content。Public Understanding of Science,8,35-50。 | 39. | Funtowicz, S.、Shepherd, I.、Wilkinson, D.、Ravetz, J.(2000)。Science and Governance in the EU: A Contribution to the Debate。Science and Public Policy,27(5),326-327。 | 40. | Hill, S.、Turpin, T.(1994)。Academic Research Culture in Collision。Science and Culture,4,327-362。 | 41. | Iglehart, J. K.(1990)。Canada's Health Care System Faces Its Problems。New England Journal of Medicine,322,562。 | 42. | Jasanoff, S.(2000)。Between Risk and Precaution: Reassessing the Future of Genetically Modified Crops。Journal of Risk Research,3(3),277-282。 | 43. | Koch, Lene(1993)。The Genefication of Medicine and the Concept of Disease。Diskussionpapier,1/93。 | 44. | Kyriakou, D.、Di Pietro, G.(2000)。Editorial。IPTS Report,45。 | 45. | Lewis, G.、Abraham, J.(1998)。Making harmonization work: the politics of scientific expertise in European medicines regulation。Science and Public Policy,25(3),160-170。 | 46. | Mathew, C.(2001)。Science, medicine, and the future: Postgenomic technologies: hunting the genes for common disorders。BMJ,322(7293),1031-1034。 | 47. | Morris, J.(2002)。The precautionary principle and biotechnology。International Journal of Biotechnology,4(1),46-60。 | 48. | Rammert, Werner(1982)。Technik und Gesellschaft: ein Überblick über die Öffentliche und sozialwissenschaftliche Technikdiskussion。Technik und Gesellschaft: Jahrbuch,1,13-47。 | 49. | Ronit, K.、Schneider, V.(1999)。Global Governance through Private Organisations。Governance,12(3),243-266。 | 50. | Salter, B.(1995)。Medicine and the state: redefining the concordat。Public Policy and Administration,10(3),60-87。 | 51. | Salter, B.(1999)。Change in the government of medicine: the politics of self-regulation。Policy and Politics,27(2),143-158。 | 52. | Sassi, F.(1996)。Health technology assessment: an introduction。Eurohealth,2(4),9-10。 | 53. | Savill, J.(1997)。Science, medicine, and the future: Prospecting for gold in the human genome。BMJ,314(7073),43-45。 | 54. | Van Eeten, M. J. G.(1999)。'Dialogues of the Deaf' on Science in Policy Controversies。Science and Public Policy,26(3),185-192。 | 55. | Biesecker, B. B.、Marteau, T. M.(1999)。The future of genetic counseling: an international perspective。Nature Genetics,22,133-137。 | 56. | Bonß, W.(1991)。Unsicherheit und Gesellschaft: Argumente für eine soziologische Risikoforschung。Soziale Welt,42,258-277。 | 57. | Botstein, D.、White, R. L.、Skolnick, M.、Davis, R. W.(1980)。Construction of A Genetic Linkage Map in Man Using Restriction Fragment Length Polymorphisms。American Journal of Human Genetics,32(3),314-331。 | 58. | Cairns, J.、Shackley, P.(1993)。Sometimes sensitive, seldom specific: a review of the economics of screening。Health Economics,2(1),43-53。 | 59. | Caulfield, T.(1999)。Gene testing in the biotech century: Are physicians ready?。CMAJ,161(9),1122-1124。 | 60. | Colby, Jeremy A.(1998)。An Analysis of Genetic Discrimination Legislation Proposed by the 105th Congress。American Journal of Law & Medicine,24(4),443-480。 | 61. | Cowley, G.(1996)。Flunk the gene test and lose your insurance。Newsweek,128(26),48-50。 | 62. | Doem, G. B.、Reed, T.(2001)。Science and Scientists in Regulatory Governance: A Mezzo-Level Framework for Analysis。Science and Public Policy,28(3),195-204。 | 63. | Dunbar-Jacob, J.、Dwyer, K.、Dunning, E. J.(1991)。Compliance with Anti-hypertensive Regimen: A Review of the Research in the 1980s。Annals of Behavioral Medicine,13(1),31-39。 | 64. | Dworkin, Ronald(1999)。Die falsche Angst, Gott zu spielen。Die Zeit,38。 | 65. | Fasouliotis, S.、Schenker, J.(2000)。BRCA1 and BRCA2 gene mutations: decision-making dilemmas concerning testing and management。Obstet Gynecol Survey,55(6),373-384。 | 66. | Feyerabend, Erika(1997)。Gentests im Vorsorgestaat。Alaska,211/212,38-40。 | 67. | Fischhoff, B.(2000)。Scientific Management of Science。Policy Science,31(1),73-87。 | 68. | Flower, Michael J.、Heath, Deborah(1993)。Micro-Anatomo Politics: Mapping the Human Genome Project。Culture, Medicine and Psychiatry,17,27-41。 | 69. | Foucar, E.(2001)。Predictive genetics and predictive morphology have certain similarities。BMJ,323(7311),514。 | 70. | Frewer, L.(1999)。Risk Perception, Social Trust, and Public Participation in Strategic Decision Making: Implications for Emerging Technologies。AMBIO,28(6),569-574。 | 71. | Gibbons, Michael(1999)。Science's New Social Contract with Society。Nature,402,C81-C85。 | 72. | Grimes, D. A.、Schulz, K. F.(2002)。Uses and abuses of screening tests。Lancet,359(9309),881-884。 | 73. | Hellstrom, T.(2000)。Technoscientific expertise and the significance of policy cultures。Technology in Society,22(4),499-512。 | 74. | Holtzman, N. A.、Marteau, T. M.(2000)。Will genetics revolutionize medicine?。New England Journal of Medicine,343(2),141-144。 | 75. | Hull, S. C.、Prasad, K.(2001)。Reading between the Lines: Direct-to-consumer Advertising of Genetic Testing。Hasting Center Report,31(3),33-35。 | 76. | Kahan, J.(1996)。Health Care Assessment Studies: A Rethink。Eurohealth,2(4),15-17。 | 77. | Kautert, P. A.(2000)。Health Policy and the New Genetics。Social Science and Medicine,51(6),821-829。 | 78. | Klarman, H. E.(1974)。Application of cost-benefit analysis to the health services and a special case of technological innovation。International Journal of Health Services,4,325-352。 | 79. | Knoppers, B. M.、Hirtle, M.、Glass, K. C.(1999)。Commercialization of Genetic Research and Public Policy。Science,286(5448),2277-2278。 | 80. | Lehoux, P.、Blume, S.(2000)。Technology Assessment and the Sociopolitics of Health Technologies。Journal of Health Politics, Policy and Law,25(6),1083-1120。 | 81. | Lippman, Abby(1991)。Prenatal genetic testing and screening: constructing needs and reinforcing inequities。American Journal of Law & Medicine,17(1/2),15-50。 | 82. | Levidow, L.(1996)。Special Issue on Biotechnology Risk Regulation in Europe。Science and Public Policy,23,133-200。 | 83. | Levidow, L.(1999)。Britain's Biotechnology Controversy: Elusive Science, Contested Expertise。New Genetics and Society,18(1),47-64。 | 84. | Levidow, L.、Carr, S.(2000)。UK: Precautionary Commercialization。Journal of Risk Research,3(3),261-270。 | 85. | Manin, B.(1987)。On Legitmacy and Political Deliberation。Political Theory,15,338-368。 | 86. | Marteau, T. M.、Lerman, C.(2001)。Genetic Risk and Behavioral Change。British Medical Journal,322(7293),1056-1059。 | 87. | Martin, P.、Kaye, J.(2000)。The Use of Large Biological Sample Collections in Genetics Research: Issues for Public Policy。New Genetics and Society,19(2),165-191。 | 88. | Martin, S. P.、Ulrich, C. D.(2000)。Pancreatic cancer surveillance in a high-risk cohort. Is it worth the cost?。Medical Clinical in North America,84(3),739-747。 | 89. | Melzer, D.、Zinunem, R.(2002)。Genetics and medicalisation。BMJ,324,863-864。 | 90. | Millstone, E.、Van Zwanenberg, P.(2001)。Politics of Expert Advice: Lessons from the Early History of the BSE Sage。Science and Public Policy,28(2),99-112。 | 91. | Mintzes, B.(2002)。Direct to Consumer Advertising Is Medicalising Normal Human Experience。British Medical Journal,324,904-911。 | 92. | Moldurp, C.、Morgall, J. M.(2001)。Risks of Future Drugs: A Danish Expert Delphi。Technological Forecasting and Social Change,67(2/3),273-289。 | 93. | Mushlin, A. I.、Ruchlin, H. S.、Callahan, M. A.(2001)。Cost effectiveness of diagnostic tests。Lancet,358(9290),1353-1355。 | 94. | Nakayama, Take、Budgell, Brian、Tsutani, Kiichiro(2003)。Confusion about the concept of clinical practice guidelines in Japan: on the way to a social consensus。International Journal for Quality in Health Care,15,359-360。 | 95. | Novas, Carlos、Rose, Nikolas(2000)。Genetic Risk and the Birth of the Somatic Individual。Economy & Society,29(4),485-513。 | 96. | Ong, Aihwa(1997)。A Better Tomorrow? The Struggle for Global Visibility。Sojourn,12(2),192-225。 | 97. | Paula, L.(2001)。Ethics: the Key to Public Acceptance of Biotechnology?。Biotechnology and Development Monitor,47,22-23。 | 98. | Pelletier, D.、Duffeld, C. H.、Adams, A.、Crisp, J.、Nagy, S.、Murphy, J.(1996)。The Impact of the Technological Care Environment on the Nursing Role。International Journal of Technology Assessment in Health Care,12(2),358-366。 | 99. | Perry, S.、Gardner, E.、Thamer, M.(1997)。The Status of Health Technology Assessment World-wide。International Journal of Technology Assessment in Health Care,13,81-98。 | 100. | Petersen, A.(1998)。The New Genetics and the Politics of Public Health。Critical Public Health,8(1),59-71。 | 101. | Petersen, G. M.、Brensinger, J. D.、Johnson, K. A.、Giardiello, F. M.(1999)。Genetic testing and counseling for hereditary forms of colorectal cancer。Cancer,86(Suppl 11),2540-2550。 | 102. | Ramani, S. V.、De Looze, M. A.(2002)。Country-specific characteristics of patent applications in France, Germany and the UK in the biotechnology sectors。Technology Analysis & Strategic Management,14(4),457-480。 | 103. | Rappert, B.(1995)。Shifting Notions of Accountability in Public and Private Sector Research in the UK: Some Central Concerns。Science and Public Policy,22(6),383-390。 | 104. | Rees, J.(2002)。Complex Diseases and the New Clinical Science。Science,296,698-701。 | 105. | Regalado, A.(1999)。Mining the Genome。Technology Review,102(5),56-63。 | 106. | Robertson, Ann(2000)。Embodying risk, embodying political rationality: women's accounts of risks for breast cancer。Health, Risk and Society,2(2),219-235。 | 107. | Rose, Nikolas(1996)。The death of the social? Re-figuring the territory of government。Economy & Society,25(3),327-356。 | 108. | Steiner, C.、Powe, N.、Anderson, G.(1996)。The review process used by U.S. health care plans to evaluate new medical technology for coverage。Journal of General Inter Medicine,11,293-302。 | 109. | Stewart-Brown, S.、Farmer, A.(1997)。Screening could seriously damage your health。BMJ,314,533。 | 110. | Strohman, Richard(1994)。Epigenesis: The missing beat in biotechnology。Bio/Technology,1,156-164。 | 111. | Swales, J. D.(1999)。Evidence-based Medicine and Hypertension。Journal of Hypertem,17,1511-1516。 | 112. | Tempany, C. M.、McNeil, B. J.(2001)。Advances in biomedical imaging。JAMA,285(5),562-567。 | 113. | The AGREE Collaboration(2000)。Guideline development in Europe: an international comparison。International Journal of Technology Assessment in Health Care,16(4),1036-1046。 | 114. | Tugwell, P.、Sitthi-Amon, C.、O'Connor, A.、Hatcher-Roberts, J.、Bergevin, Y.、Wolfson, M.(1995)。Technology Assessment: Old, New and Needed-based。International Journal of Technology Assessment in Health Care,11(4),650-652。 | 115. | Uhlemann, Thomas(1999)。Gentests aus dem Internet。Gen-Ethischer Informationsdienst,15(134),3-5。 | 116. | Weinstein, M. C.、Stason, W. B.(1977)。Foundations of Cost-Effectiveness Analysis for Health and Medical Practices。New England Journal of Medicine,296,716-721。 | 117. | Weisbrod, Burton(1991)。The health care quadrilemma: An essay on technological change, insurance, quality of care, and cost containment。Journal of Economic Literature,29,523-552。 | 118. | Well, P.(1999)。Health Care and the Medical Engineering Phoenix。Science,12(4),15-21。 | 119. | Wildavsky, A.(1966)。The Political Economy of Efficiency: Cost-Benefit Analysis and Program Budgeting。Public Administration Review,26,292-310。 | 120. | Williams, Nigel(1997)。Biologists Cut Reductionist Approach Down to Size。Science,277(5325),476-477。 | 121. | Willison, D. J.、MacLeod, S. M.(2002)。Patenting of genetic material: Are the benefits to society being realized?。CMAJ,167(2),262-264。 | 122. | Woolf, S. H.、Henshal, C.(2000)。Technology assessment in the United Kingdom。International Journal of Technology Assessment in Health Care,16,591-625。 | 123. | Rose, Nikolas、Miller, Peter(1999)。What is post normal science?。Futures,31(7),647-653。 | 124. | Pinch, Trevor J.、Bijker, Wiebe E.(1984)。The Social Construction of Facts and Artefacts: or How the Sociology of Science and the Sociology of Technology Might Benefit Each Other。Social Studies of Science,14(3),399-441。 | 125. | Heller, M. A.、Eisenberg, R. S.(1998)。Can patents deter Innovation?。Science,280,671-698。 | 126. | 周桂田(20000900)。生物科技產業與社會風險--遲滯型高科技風險社會。臺灣社會研究,39,239-283。 延伸查詢 | 127. | De Marchi, Bruna、Ravetz, Jerome R.(1999)。Risk management and governance: a post-normal science approach。Futures,31,743-757。 | 128. | 吳基福(19780900)。中國醫學史及其科學化的問題。臺灣醫界,21(9-11),7-11。 延伸查詢 | 129. | Newhouse, J. P.(1992)。Medical Care Costs: How Much Welfare Loss?。Journal of Economic Perspectives,6(3),3-21。 | 130. | Fuchs, Victor(19960300)。Economics, Values, and Health Care Reform。American Economic Review,86(1),1-24。 | 131. | Fischhoff, Baruch、Slovic, Paul、Lichtenstein, Sarah、Read, Stephen、Combs, Barbara(1978)。How safe is safe enough? A psychometric study of attitudes towards technological risks and benefits。Policy Sciences,9(2),127-152。 | 132. | Frewer, L. J.、Howard, C.、Hedderley, D.、Shepherd, R.(1996)。The influence of realistic product exposure on attitudes towards genetic engineering of food。Food Quality and Preference,7(1),61-67。 | 133. | Frewer, L. J.、Howard, C.、Hedderley, D.、Shepherd, R.(1997)。Public concerns in the United Kingdom about general and specific applications of genetic engineering: risk, benefit, and ethics。Science, Technology & Human Values,22(1),98。 | 134. | 周桂田(19981000)。現代性與風險社會。臺灣社會學刊,21,89-129。 延伸查詢 | 135. | Hilgartner, Stephen(1990)。The Dominant View of Popularization: Conceptual Problems, Political Uses。Social Studies of Science,20(3),519-539。 | 136. | Rose, Nikolas、Miller, Peter(1992)。Political Power beyond the State: Problematics of Government。The British Journal of Sociology,43(2),173-205。 | 137. | Rosenau, James N.(1995)。Governance in the Twenty-first Century。Global Governance,1(1),13-43。 | 會議論文1. | 顏厥安(1998)。死去活來--論法律對生命之規範。張昭鼎紀念學術研討會。台北:國立台灣大學法學院。 延伸查詢 | 2. | Organisation for Economic Co-operation and Development(2000)。Genetic testing: policy issues for the new millennium。Paris:OECD。 | 3. | Spallone, P.、Willkie, T.(1999)。Social, ethical, and public policy implications of advances in the biomedical sciences: the Wellcome Trust's initiative on pharmacogenetics。The European Workshop on Legal, Regulatory and Ethic Aspects in Pharmacogenetics,(會議日期: Nov. 12)。Berlin, Germany。 | 4. | Daemmrich, A.(1998)。The Science and Politics of Regulatory Transparency in Europe and the United States。EASST Annual Conference,(會議日期: October 1-3)。Lisbon。 | 5. | May, R.(1998)。Government Policy Towards the Science-base。Smith Kline Beecham, Annual Symposium。London。 | 6. | Smith, M.(1985)。The Cost of Non-compliance and the Capacity of Improved Compliance to Reduce Health Care Expenditures。Virginia:National Pharmaceutical Council。35-44。 | 7. | Van Ommen, G. J. B.(1999)。The Future Directions of Human Genome Research in Europe。Florence Strategy Meeting。Florence。 | 8. | Wilkie, T.(1998)。The Regulation of Human Genetics in Britain。Hertford College Regulatory Policy Research Centre Conference,(會議日期: 25 June)。Oxford。 | 研究報告1. | Miller, F. A.、Giacomini, M.(2001)。Defining the characteristics of predictive genetic tests: a framework for evaluation and decision-making。Hamilton:Subcommittee on Evaluation. Ontario Advisory Committee on New Predictive Genetic Technologies。 | 2. | Cutler, David M.、Meara, Ellen(1999)。The Technology of Birth: Is It Worth It?。Cambridge, MA。 | 3. | Cutler, David M.、McClellan, Mark、Newhouse, Joseph(1998)。The Costs and Benefits of Intensive Treatments for Cardiovascular Disease。Massachusetts, Cambridge。 | 學位論文1. | 郭淑珍(1998)。科技領域的風險決策之研究--以德國法為中心(碩士論文)。國立臺灣大學。 延伸查詢 | 圖書1. | Abraham, J.、Lewis, G.(2000)。Regulating Medicines in Europe。London:Routledge。 | 2. | Banta, H. D.、Luce, B. R.(1993)。Health Care Technology and its Assessment。Oxford:Oxford Univ. Press。 | 3. | Bertrand, U.、Kuhlmann, J.、Stark, C.(1995)。Der Gesundheitschip - Vom Arztgeheimnis zum gläsernen Patienten。Frankfurt am Main:Campus。 | 4. | Cabinet Office and Office of Science and Technology(1999)。The Advisory and Regulatory Framework for Biotechnology: Report from the Government's Review。London:Stationery Office。 | 5. | 吳基福(1979)。中國醫政史上的大革命--「醫師法」修正始末。台北:中華民國醫師公會聯合會。 延伸查詢 | 6. | Aaron, H. J.、Schwartz, W. B.(1984)。The Painful Prescription: Rationing Hospital Care。Washington, DC:Brookings Institute。 | 7. | Ashmore, Malcolm、Mulkay, M. J.、Pinch, T. J.(1989)。Health and Efficiency: A Sociology of Health Economics。Buckingham, UK:Open Univ. Press。 | 8. | Baird, P. A.(2002)。Genetic Identification of Susceptibility to Common Diseases: A New Era of Preventive Medicine?。Canada:Centre for Health Services and Policy Research, University of British Columbia。 | 9. | Chadwick, R.、Levitt, M.、Schikle, D.(1997)。The Right to Know and the Right not to Know。Aldershot:Avebury。 | 10. | Dunnin, A.(1992)。Choices in Health Care: A Report by the Government Committee on Choices in Health Care。Rijswijk:Ministry of Welfare, Health and Culture。 | 11. | Ehlert, W.(1992)。Sozialverträgliche Technikgestaltung und/oder Technisierung von Sachzwang?。Westdeutscher Verlag。 | 12. | Farber, D. A.(1999)。Ecopragmatism。Chicago:University of Chicago Press。 | 13. | Gaebler, T.、Osborne, D.(1993)。Reinventing Government。Reading, MA:Addison Wesley。 | 14. | Genetics Research Advisory Group(1995)。A First Report to the NHS Central Research and Development Committee on the New Genetics。London:Department of Health。 | 15. | Gottweis, Herbert(1998)。Governing Molecules。Cambridge:MIT Press。 | 16. | Habermas, Jürgen(1963)。Strukturwandel der Öffentlichkeit。F./M.:Suhrkamp。 | 17. | House of Commons, UK(1999)。Science and technology: first report。London:Science and Technology Committee Publications。 | 18. | Hubbard, Ruth、Wald, Elijah(1997)。Exploding the gene myth: how genetic information is produced and manipulated by scientists, physicians, employers, insurance companies, educators, and law enforcers。Boston:Beacon Press。 | 19. | Macer, D.(1998)。Public perception of biotechnology in New Zealand and the international community: Eurobarometer 46.1。Japan:Eubios Ethics Institute。 | 20. | Moran, M.、Wood, B.(1993)。State, Regulation and the Medical Profession。Buckingham:Open University Press。 | 21. | Nelkin, Dorothy、Tancredi, Laurence(1994)。Dangerous Diagnostics: The Social Power of Biological Information。Chicago:University of Chicago Press。 | 22. | Office of Technology Assessment(1995)。Coverage of Laser Technology by Health Insurers。Washington, DC:U.S. Government Printing Office。 | 23. | Ogbum, W. F.(1942)。Inventions, population and history。Indianapolis:Bobbs-Merrill。 | 24. | Whitely, R.、Kristensen, P. H.(1997)。Governance at Work: the Social Regulation of Economic Relations。Oxford University Press。 | 25. | Bourdieu, Pierre(1998)。Gegenfeuer: Wortmeldungen im Dienste des Widerstands gegen die neoliberale Invasion。Konstanz:UVK Universitätsverlag Konstanz GmbH。 | 26. | Funtowicz, S. O.、Ravetz, J. R.(1990)。Uncertainty and Quality in Science for Policy。Dordrecht, Germany:Kluwer。 | 27. | Gelijns, A. D.(1990)。Modern Methods of Clinical Investigation。Washington, DC:National Academy Press。 | 28. | Gill, B.、Bizer, J.、Roller, G.(1998)。Riskante Forschung: zum Umgang mit Ungewissheit am Beispiel der Genforschung in Deutschland: eine sozial- und rechtswissenschaftliche Untersuchung。Berlin:Sigma。 | 29. | Habermas, Jürgen(1996)。Die gesellschaftliche "Natur" der Technik. Eine Einführung in die soziologische Theorie der Technik。Opladen:Leske & Budrich。 | 30. | Kay, Lily E.(2000)。Who Wrote the Book of Life?: A History of the Genetic Code。Stanford, CA:Stanford University Press。 | 31. | Keasey, K.(1997)。Corporate Governance。Oxford:Oxford University Press。 | 32. | Keller, Evelyn Fox(2000)。The Century of the Gene。Cambridge, MA:Harvard University Press。 | 33. | Latour, Bruno(1995)。Wir sind nie modern gewesen--Versuch einer symmetrischen Anthropologie。Berlin:Akademie Verlag。 | 34. | MacKenzie, D.、Wajcman, J.(1985)。The Social Shaping of Technology。London。 | 35. | Nowotny, H.、Gibbons, M.、Scott, P.(2001)。Re-thinking Science: Knowledge and the Public in the Age of Uncertainty。Cambridge:Polity Press。 | 36. | Offit, K.(1998)。Clinical Cancer Genetics: Risk Counseling and Management。New York:Wiley-Liss。 | 37. | Patel, K.、Rushefsky, M. E.(1995)。Health Care Politics and Policy in America。New York:M.E. Sharpe。 | 38. | Quarantelli, E. L.(1998)。What is a disaster? Perspectives on the question。New York:Routledge。 | 39. | Rammert, Werner(1993)。Technik aus soziologischer Perspektive。Westdeutscher Verlag。 | 40. | Rettig, R. A.(1997)。Health Care in Transition: Technology Assessment in the Private Sector。Santa Monica, CA:RAND。 | 41. | Rothstein, Mark A.(1997)。Genetic Secrets: Protecting Privacy and Confidentiality in the Genetic Era。Yale University Press。 | 42. | Schmidtke, Jörg(1997)。Vererbung und Ererbtes - Ein humangenetischer Ratgeber。Reinbek:Rowohlt。 | 43. | Seligman, A. B.(1997)。The Problem of Trust。Princeton, NJ:Princeton University Press。 | 44. | Steiner, C.、Powe, N.、Anderson, G.(1995)。Technology Coverage Decisions and Considerations Used by Health Plans。Washington, DC:Office of Technology Assessment。 | 45. | Stern, P. C.、Fineberg, H.(1996)。Understanding Risk: Informing Decision in a Democratic Society。Washington, DC:National Academy Press。 | 46. | Winner, L.(1992)。Democracy in a Technological Society。Dordrecht:Kluwer。 | 47. | Cutler, A. Claire、Haufler, Virginia、Albany, Tony Porter(1999)。Private Authority and International Affairs。New York:State University of New York Press。 | 48. | Kickert, W. J.、Klijin, E.、Koppenjan, J.(1997)。Managing Complex Networks。Sage。 | 49. | Kettl, D. F.(1993)。Sharing Power: Public Government and Private Markets。Washington, D. C.:The Brookings Institution。 | 50. | Beck, Ulrich(1988)。Gegengifte: Die organisierte Unverantwortlichkeit。Frankfurt am Main:Suhrkamp。 | 51. | Bijker, Wiebe E.(1995)。Of Bicycles, Bakelites, and Bulbs: Toward a Theory of Sociotechnical Change。Cambridge, MA:MIT Press。 | 52. | Schmidt-Aßmann, Eberhard(1998)。Das allgemeine Verwaltungsrecht als Ordnungsidee: Grundlagen und Aufgaben der verwaltungsrechtlichen Systembildung。Berlin:Springer Verlag。 | 53. | Perrow, Charles(1999)。Normal Accidents: Living with High-Risk Technologies。Princeton University Press。 | 54. | Lupton, Deborah(1995)。The Imperative of Health: Public Health and the Regulated Body。Sage Publications。 | 55. | Foucault, Michel、Hurley, Robert(1979)。The History of Sexuality (Vol.1) : An Introduction。London:Allen Lane。 | 56. | Beck, Ulrich(1999)。World Risk Society。Polity Press。 | 57. | Habermas, Jürgen(1994)。Faktizität und Geltung: Beiträge zur Diskurstheorie des Rechts und des demokratischen Rechtsstaats。Suhrkamp。 | 58. | Fukuyama, F.(1995)。Trust: The Social Values and the Creation of Prosperity。New York:Free Press。 | 59. | Luhmann, Niklas(1986)。Ökologische Kommunikation: Kann die moderne Gesellschaft sich auf ökologische Gefährdungen einstellen?。 | 60. | Jasanoff, Sheila(1990)。The Fifth Branch: Science Advisors as Policymakers。Cambridge, Mass:Harvard University Press。 | 61. | Perrow, Charles、蔡承志(2001)。當科技變成災難--與高風險系統共存。台北:商周。 延伸查詢 | 62. | Mileti, Dennis S.(1999)。Disasters by design: A reassessment of natural hazards in the United States。Joseph Henry Press。 | 63. | Beck, Ulrich、Ritter, Mark A.(1997)。The Reinvention of Politics: Rethinking Modernity in the Global Social Order。Cambridge, Mass:Polity Press。 | 64. | Beck, Ulrich(1993)。Die Erfindung des Politischen: Zu einer Theorie reflexiver Modernisierung。Frankfurt am Main:Suhrkamp Verlag。 | 65. | Andrews, Lori B.、Nelkin, Dorothy、廖月娟(2001)。出賣愛因斯坦:人體組織販賣市場。台北市:時報文化公司。 延伸查詢 | 66. | Beck, Ulrich(1992)。Risk society: Toward a new modernity。London:Sage。 | 67. | Douglas, Mary、Wildavsky, Aaron(1982)。Risk and Culture: An Essay on the Selection of Technical and Environmental Dangers。University of California Press。 | 68. | Porter, Theodore M.(1995)。Trust in Numbers: The Pursuit of Objectivity in Science and Public Life。NJ:Princeton University Press。 | 69. | Beck, Ulrich、汪浩(2004)。風險社會--通往下一個現代的路上。臺北:巨流。 延伸查詢 | 70. | Bohman, James(1996)。Public Deliberation: Pluralism, Complexity, and Democracy。MIT Press。 | 71. | Giddens, Anthony(1998)。The Third Way: The Renewal of Social Democracy。Oxford:Blackwell publishers Ltd.。 | 72. | Lupton, Deborah(1999)。Risk。Routledge。 | 73. | Japp, Klaus Peter(1996)。Soziologische Risikotheorie. Funktionale Differenzierung, Politisierung und Reflexion。München:Juventa-Verlag。 | 74. | Beck, Ulrich(1986)。Risikogesellschaft: Auf dem Weg in einen andere Moderne。Frankfurt am Main:Suhrkamp。 | 75. | Luhmann, Niklas(1991)。Soziologie des Risikos。Walter de Gruyter。 | 76. | Giddens, Anthony(1990)。The Consequences of Modernity。Stanford, CA:Stanford University Press。 | 77. | Rhodes, Robert A. W.(1997)。Understanding Governance: Policy Networks, Governance, Reflexivity and Accountability。Open University Press。 | 78. | Benhabib, Seyla(1996)。Democracy and Difference: Contesting the Boundaries of the Political。Princeton University Press。 | 79. | Haraway, Donna Jeanne(1990)。Simians, Cyborgs, and Women: The Reinvention of Nature。Routledge。 | 80. | Stone, Deborah A.(1997)。Policy paradox: The art of political decision making。New York:W. W. Norton & Company。 | 81. | Fishkin, James S.(1991)。Democracy and Deliberation: New Directions for Democratic Reform。Yale University Press。 | 82. | Blaikie, Piers M.、Cannon, Terry、Davis, Ian、Wisner, Ben(1994)。At Risk: Natural Hazards, People's Vulnerability and Disasters。Routledge。 | 83. | Luhmann, Niklas、Bednarz, John Jr.、Baecker, Dirk(1995)。Social Systems。Stanford, California:Stanford University Press。 | 其他1. | Abraham, C.(19990827)。Tenacious Woman Scores Medical Victory。 | 2. | Department of Health(2003)。Our inheritance, our future: realising the potential of genetics in the NHS。 | 3. | National Bioethics Advisory Commission(1999)。Research Involving Human Biological Materials: Ethical Issues and Policy Guidance Executive Summary,http://bioethics.gov/pubs.html。 | 4. | Shanne, Laura(2001)。Embryonic Stem Cell Research: Canadian Policy and Ethical Considerations-- A Report for Health Canada, Policy Division,http://www.msu.edu/hlnelson/fab/Shanner_Stem_Cell_Policy.pdf。 | 5. | Crawford, D. C.(2002)。Human Diversity: Impact on Genetic Testing and Screening,http://www.cdc.gov/genomics/info/reports/program/Diversity.htm。 | 圖書論文1. | Marsh, David(1998)。The Development of the Policy Network Approach。Comparing Policy Networks。Buckingham:Open University Press。 | 2. | Abraham, J.(1997)。The science and politics of medicines regulation。The sociology of medical science and technology。Oxford:Blackwell Publishers。 | 3. | CEC(2000)。Enhancing Democracy in the European Union。White Paper on European Governance: Commission Staff Working Document。Luxembourg:OOPEC。 | 4. | Dahl, Robert(1989)。A Theory of Democratic Processes。Democracy and Its Critics。New Haven, CT:Yale University Press。 | 5. | Deleuze, Gilles(1993)。Postskriptum über die Kontrollgesellschaften。Unterhandlungen: 1972-1990。Frankfurt a. M.:Suhrkamp。 | 6. | Elston, M. A.(1997)。Introduction: the sociology of medical science and technology。The Sociology of Medical Science and Technology。Oxford:Blackwell Publishers。 | 7. | Funtowicz, S. O.、Ravetz, J. R.(1993)。Three types of risk assessment and the emergence of post-normal science。Social theories of risk。London:Praeger。 | 8. | Gaudillière, Jean-Paul(1995)。Sequenzieren, Zählen und Vorhersehen. Praktiken einer Genverwaltung。Zur Aktualität von Michel Foucault. Wissen und Macht- Die Krise des Regierens。Tübingen:TAV。 | 9. | Gottweis, Herbert(1997)。Genetic Engineering, Discourses of Deficiency, and the New Politics of Population。Changing Life: Genomes, Ecologies, Bodies, Commodities。Minneapolis:University of Minnesota Press。 | 10. | Guston, D. H.(2002)。CRIs in the wilderness: Toward centers for responsible innovation in the commercialized academy。The commercialization of the American research university。New Brunswick:Rutgers University Press。 | 11. | Hill, A.、Michael, M.(1998)。Engineering acceptance: Representations of "The Public" in debates on biotechnology。The Social Management of Genetic Engineering。Aldershot:Ashgate。 | 12. | Hitzler, Ronald(1998)。Reflexive Kompetenz - zur Genese und Bedeutung von Expertenwissen jenseits des Professionalismus。Expertenwissen: Soziologische, psychologische und pädagogische Perspektiven。Opladen:Leske+Budrich。 | 13. | Hoffmann-Riem, Wolfgang(1993)。Ansaetze am Beispiel des Umweltschutz。Reform des Allgemeinen Verwaltungsrechts。Baden-Baden:Grundfragen。 | 14. | Jonsen, Albert R.(1996)。The impact of mapping the Human Genome on the Patient-Physician Relationship。The Human Genome Project and the Future of Health Care。Indiana University Press。 | 15. | Metcalfe, S. J.(1997)。Technology systems and technology policy in an evolutionary framework。Technology, Globalization and Economic Performance。Cambridge, MA:The Syndicate of the University of Cambridge Press。 | 16. | Milward, A. S.(1997)。The Springs of Integration。The Question of Europe。London:Verso。 | 17. | Rheinberger, Hans-Jörg(1997)。Von der Zelle zum Gen: Repräsentationen der Molekularbiologie。Räume des Wissens: Repräsentation, Codierung, Spur。Berlin:Akademie Verlag。 | 18. | Sohn, W.(1994)。Zwischen technologischen Aufhebung der Gesellschaft und Politisierung der Technologies。Geselllschaft im Übergang -Perspektiven kritischer Soziologie。Darmstadt。 | 19. | Woolgar, S.(1996)。Psychology, qualitative methods and the ideas of science。Handbook of Qualitative Research Methods。British, Leicester:Psychological Society。 | 20. | Bijker, W. E.(1987)。The social construction of Bakelite: Towards a theory of invention。The social construction of technological systems。Cambridge, Mass:MIT Press。 | 21. | Corin, E.(1994)。The Social and Cultural Matrix of Health Disease。Why are Some People Healthy and Others Not?。New York:Aldin De Gruyter。 | 22. | Davison, Charlie(1996)。Predictive genetics: the cultural implications of supplying probable futures。The troubled helix: social and psychological implications of the new human genetics。Cambridge:Cambridge University Press。 | 23. | Fiorino, Daniel J.(1996)。Environmental Policy and the Participation Gap。Democracy and the Environment: Problems and Prospects。Edward Elgar。 | 24. | Forst, Rainer(1994)。Zivilgesellschaft und deliberative Demokratie。Kontexte der Gerechtigkeit: Politische Philosophie jenseits von Liberalismus und Kommunitarismus。Suhrkamp。 | 25. | Foucault, Michel(1985)。Discourse and Truth: The Problematization of Parrhesia。Discourse and Truth。Evanston, Illinois:Northwestern University。 | 26. | Gabe, J.(1995)。Health, Medicine and Risk: The need for a Sociological Approach。Medicine, Health and Risk: Sociological Approaches。Oxford:Blackwell。 | 27. | Gloede, F.(1994)。Technikpolitik, Technikfolgenabschätzung und Partizipation。Interdisziplinäre Technikforschung: Genese, Folgen, Diskurs。Frankfurt am Main:Campus。 | 28. | Hallowell, Nina(1999)。Doing the right thing: genetic risk and responsibility。Sociological Perspectives on the New Genetics。Oxford:Blackwell。 | 29. | Hoffman, S. M.、Oliver-Smith, A.(1999)。Anthropology and the angry earth: an overview。The Angry Earth: Disaster in Anthropological Perspective。New York:Routledge。 | 30. | Hughes, T. P.(1987)。The Evolution of Large Technical Systems。The Social Construction of Technological Systems。Cambridge, MA:MIT Press。 | 31. | Keller, Evelyn Fox(1992)。Nature, Nurture, and the Human Genome Project。The Code of Codes. Scientific and Social Issues in the Human Genome Project。Cambridge, MA:Harvard University Press。 | 32. | Klijin, E.(1997)。Policy Networks: an Overview。Managing Complex Networks。London:Sage。 | 33. | Lemke, Thomas(2000)。Die Regierung der Risiken: von der Eugenik zur genetischen Gouvernementalität。Gouvernementalität der Gegenwart: Studien zur Ökonomisierung des Sozialen。Frankfurt am Main:Suhrkamp。 | 34. | MacKean, G.、Thurston, W.(1996)。A Canadian Model of Public Participation in Health Care Planning and Decision Making。Efficiency vs. Equality: Health Care Reform in Canada。Halifax, Canada:Femwood Press。 | 35. | Mumford, L.(1986)。Technology and Culture。The Lewis Mumford Reader。New York:Pantheon。 | 36. | Nelkin, Dorothy(1992)。The Social Power of Genetic Information。The Code of Codes. Scientific and Social Issues in the Human Genome Project。Cambridge, MA:Harvard University Press。 | 37. | Petersen, A.(1997)。Risk, Governance and the New Public Health。Foucault, Health and Medicine。London:Routledge。 | 38. | Petersen, A.(1999)。Public Health, the New Genetics and Subjectivity。Poststructuralism, Citizenship and Social Policy。London:Routledge。 | 39. | Rabinow, Paul(1996)。Artificiality and enlightenment: from sociobiology to biosociality。Essays on the anthropology of reason。Princeton, NJ:Princeton University Press。 | 40. | Rapp, Rayna(1995)。Risky Business: Genetic Counseling in a Shifting World。Articulating Hidden Histories。Berkeley:University of California Press。 | 41. | Ravetz, Jerome R.(1993)。Recombinant DNA Research: Whose Risks?。The Merger of Knowledge with Power。London。 | 42. | Sackett, D. L.、Snow, J. C.(1979)。The Magnitude of Compliance and Non-compliance。Compliance in Health Care。Baltimore, MD:Johns Hopkins University Press。 | 43. | Scholz, Christine(1995)。Biographie und molekulargenetische Diagnostik。Welche Gesundheit wollen wir?: Dilemmata des medizintechnischen Fortschritts。Frankfurt:Suhrkamp。 | 44. | Telling, F.(1990)。Managed care and pharmaceutical innovation。Technology and health care in an era of limits。Washington, DC:National Academy Press。 | 45. | Van den Daele, Wolfgang(1992)。Scientific Evidence and the Regulation of Technical Risks: Twenty Years of Demythologizing the Experts。The Culture and Power of Knowledge。Berlin:Walter de Gruyter & Co。 | 46. | Wallack, L.(1990)。Mass Media and Health Promotion: Promise, Problem, and Challenge。Mass Communication and Public Health。Newbury Park:Sage。 | 47. | Yeo, M.(1996)。The Ethics of Public Participation。Efficiency vs. Equality: Health Care Reform in Canada。Halifax, Canada:Femwood Press。 | 48. | Yoxen, Edward J.(1984)。Constructing Genetic Diseases。Cultural Perspectives on Biological Knowledge。Norwood, NJ:Ablex Publishing Corporation。 | 49. | Callon, M.(1987)。Society in the Marketing: The Study of Technology as a Tool for Sociological Analysis。The Social Construction of Technological Systems。London:MIT Press。 | 50. | Rayner, Steve(1992)。Cultural Theory and Risk Analysis。Social Theories of Risk。Praeger Publischer。 | 51. | Lash, Scott(1994)。Reflexivity and its Doubles: Structure, Aesthetics, Community。Reflexive Modernization: Politics, Tradition and Aesthetics in the Modern Social Order。Cambridge:Polity Press。 | 52. | McGuire, W. J.(1985)。Attitudes and Attitude Change。Handbook of Social Psychology。Hillsdale , NJ:Lawrence Erlbaum。 | 53. | Cohen, Joshua(1989)。Deliberation and Democratic Legitimacy。The Good Polity: Normative Analysis of the State。Oxford:Basil Blackwell。 | 54. | Habermas, Jürgen(1992)。Drei normative Modelle der Demokratie: Zum Begriff deliberativer Politik。Die Chancen der Freiheit: Grundprobleme der Demokratie。München:Piper Verlag。 | 55. | 李震山(2000)。論資訊自決權。人性尊嚴與人權保障。元照。 延伸查詢 | |